Abstract

Low-density lipoprotein oxidation and antioxidant vitamins E and C were investigated in dipper (nocturnal blood pressure fall > 10%) and nondipper (nocturnal blood pressure fall < 10%) hypertensives. We studied 40 dippers and 28 nondippers balanced for gender, age, and body mass index. Blood samples were drawn for lipid profile determination, assessment of thiobarbituric acid-reactive substances, and fluorescent products of lipid peroxidation in native low-density lipoprotein, evaluation of susceptibility to low-density lipoprotein oxidation in vitro (lag phase and propagation rate), and determination of low-density lipoprotein vitamin E and plasma vitamins E and C contents. Compared with dippers, nondippers had significantly higher thiobarbituric acid-reactive substances and fluorescent products of lipid peroxidation (0.63 ± 0.1 v 0.77 ± 0.08 nmol malondialdehyde/mg low-density lipoprotein protein, and 14.5 ± 6 v 17.9 ± 4 units of relative fluorescence/mg low-density lipoprotein protein, respectively, both P <.05), shorter lag phase (56 ± 13 v 49 ± 9 min, P <.05), and lower plasma vitamin C content (42 ± 9 v 35 ± 10 μmol/L, P <.05). When gender was taken into account, differences were not significant between dipper and nondipper men, whereas, compared with dipper women, nondipper women showed significantly higher thiobarbituric acid-reactive substances and fluorescent products of lipid peroxidation (0.56 ± 0.1 v 0.77 ± 0.07 nmol malondialdehyde/mg low-density lipoprotein protein, and 12.5 ± 4 v 17.5 ± 4.6 units of relative fluorescence/mg low-density lipoprotein protein, respectively, both P < .05), shorter lag phase (62.5 ± 11 v 49 ± 9.5 min, P < .05), and lower plasma vitamin C content (44.9 ± 10 v 34.7 ± 10.8 μmol/L, P < .05). Given the role of low-density lipoprotein oxidation in the pathogenesis of atherosclerosis and that of vitamin C in protecting against it, our data suggest that nondippers, especially among women, show higher atherogenic risk than dippers. Am J Hypertens 1999;12:356–363 © 1999 American Journal of Hypertension, Ltd.

References

1.
Mancia
G
,
Ferrari
A
,
Gregorini
L
et al.  
:
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings
.
Circ Res
 
1983
;
53
:
96
104
.
2.
Weber
MA
,
Drayer
JIM
,
Nakamura
DK
,
Wyle
FA
:
The circadian blood pressure pattern in ambulatory normal subjects
.
Am J Cardiol
 
1984
;
45
:
115
119
.
3.
Pickering
TG
:
Diurnal, ultradian and seasonal rhythms of blood pressure
, in
Pickering
TG
(ed):
Ambulatory Monitoring and Blood Pressure Variability
 .
1991
Science Press
,
London
,
5.1
5.15
.
4.
O'Brien
E
,
Sheridan
J
,
O'Malley
K
:
Dippers and non-dippers (letter)
.
Lancet
 
1988
;
ii
:
397
.
5.
Verdecchia
P
,
Schillaci
G
,
Guerrieri
M
et al.  
:
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension
.
Circulation
 
1990
;
81
:
528
536
.
6.
Kobrin
I
,
Oigman
W
,
Kumar
A
et al.  
:
Diurnal variation of blood pressure in elderly patients with essential hypertension
.
J Am Geriatr Soc
 
1984
;
32
:
896
899
.
7.
Shimada
K
,
Kawamoto
A
,
Matsubayashi
K
et al.  
:
Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension
.
J Hypertens
 
1992
;
10
:
875
878
.
8.
Palatini
P
,
Penzo
M
,
Racioppa
A
et al.  
:
Clinical relevance of nighttime blood pressure and of daytime blood pressure variability
.
Arch Intern Med
 
1992
;
152
:
1855
1860
.
9.
Verdecchia
P
,
Schillaci
G
,
Boldrini
F
et al.  
:
Sex cardiac hypertrophy and diurnal blood pressure variations in essential hypertension
.
J Hypertens
 
1992
;
10
:
683
692
.
10.
Suzuki
Y
,
Kuwajima
I
,
Kanemaru
A
et al.  
:
The cardiac functional reserve in elderly hypertensive patients with abnormal diurnal change in blood pressure
.
J Hypertens
 
1992
;
10
:
173
179
.
11.
Schmieder
RE
,
Rockstroh
JK
,
Aepfelbacher
F
et al.  
:
Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertension
.
Am J Hypertens
 
1995
;
8
:
1160
1166
.
12.
Verdecchia
P
,
Porcellati
C
,
Schillaci
G
et al.  
:
Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension
.
Hypertension
 
1994
;
24
:
793
801
.
13.
Ohkubo
T
,
Imai
Y
,
Tsuji
T
et al.  
:
Relation between nocturnal decline in blood pressure and mortality: the Ohasama Study
.
Am J Hypertens
 
1997
;
10
:
1201
1207
.
14.
Zweiker
R
,
Eber
B
,
Schumacher
M
et al.  
:
“Non-dipping” related to cardiovascular events in essential hypertensive patients
.
Acta Med Austriaca
 
1994
;
21
:
86
89
.
15.
Suzuki
Y
,
Kuwajima
I
,
Aono
T
et al.  
:
Prognostic value of ambulatory blood pressure in elderly hypertensive patients: dipper vs non-dipper
.
J Hypertens
 
1996
;
14
(
suppl 1
):
S381
.
16.
Pierdomenico
SD
,
Lapenna
D
,
Guglielmi
MD
et al.  
:
Arterial disease in dipper and nondipper hypertensive patients
.
Am J Hypertens
 
1997
;
10
:
511
518
.
17.
Roman
MJ
,
Pickering
TG
,
Schwartz
JE
et al.  
:
Is the absence of a normal nocturnal fall in blood pressure (nondipping) associated with cardiovascular target organ damage?
.
J Hypertens
 
1997
;
15
:
969
978
.
18.
Cuccurullo
F
,
Porreca
E
,
Lapenna
D
et al.  
:
Aortic glutathione-related antioxidant defenses in rabbits subjected to suprarenal aortic coarctation hypertension
.
J Mol Cell Cardiol
 
1991
;
23
:
727
734
.
19.
Nakazono
K
,
Watanabe
N
,
Matsuno
K
et al.  
:
Does superoxide underlie the pathogenesis of hypertension?
.
Proc Natl Acad Sci USA
 
1991
;
88
:
10045
10048
.
20.
Sagar
S
,
Kallo
JI
,
Kaul
N
et al.  
:
Oxygen free radicals in essential hypertension
.
Mol Cell Biochem
 
1992
;
111
:
103
108
.
21.
Sharma
RC
,
Crawford
DW
,
Kramsch
DM
et al.  
:
Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and atherosclerotic arteries: role of oxygen free radicals
.
Arterioscler Thromb
 
1992
;
12
:
403
415
.
22.
Jameson
M
,
Dai
FX
,
Lusher
T
et al.  
:
Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension
.
Hypertension
 
1993
;
21
:
280
288
.
23.
Kumar
KW
:
Das UM
.
Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun
 
1993
;
19
:
59
66
.
24.
De Bruyn
VH
,
Nuno
DW
,
Cappelli-Bigazzi
M
et al.  
:
Effect of acute hypertension in coronary circulation: role of mechanical factors and oxygen radicals
.
J Hypertens
 
1994
;
12
:
163
172
.
25.
Alexander
RW
:
Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response–a new perspective
.
Hypertension
 
1995
;
25
:
155
161
.
26.
Lacy
F
,
O'Connor
DT
,
Schmid-Schönbein
GW
:
Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension
.
J Hypertens
 
1998
;
16
:
291
303
.
27.
Steinberg
D
,
Parthasarathy
S
,
Carew
TE
et al.  
:
Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity
.
N Engl J Med
 
1989
;
320
:
915
924
.
28.
Kugiyama
K
,
Kerns
SA
,
Morrisset
JD
et al.  
:
Impairment of endothelium-dependent arterial relaxation by lisolecithin in modified low density lipoprotein
.
Nature
 
1990
;
344
:
160
162
.
29.
Simon
BC
,
Cunningham
LD
,
Cohen
RA
:
Oxidised low density lipoprotein cause contraction and inhibit endo-thelium-dependent relaxation in the pig coronary artery
.
J Clin Invest
 
1990
;
86
:
75
79
.
30.
Maggi
E
,
Marchesi
E
,
Ravetta
V
et al.  
:
Low-density lipoprotein oxidation in essential hypertension
.
J Hypertens
 
1993
;
11
:
1103
1111
.
31.
Keidar
S
,
Kaplan
M
,
Shapira
C
et al.  
:
Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II
.
Atherosclerosis
 
1994
;
107
:
71
84
.
32.
Maggi
E
,
Marchesi
E
,
Ravetta
V
et al.  
:
Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation
.
J Hypertens
 
1995
;
13
:
129
138
.
33.
Pierdomenico
SD
,
Costantini
F
,
Bucci
A
et al.  
:
Low-density lipoprotein oxidation and vitamins E and C in sustained and white-coat hypertension
.
Hypertension
 
1998
;
31
:
621
626
.
34.
Frei
B
,
England
L
,
Ames
BN
:
Ascorbate is an outstanding antioxidant in human blood plasma
.
Proc Natl Acad Sci USA
 
1989
;
86
:
6377
6381
.
35.
Esterbauer
H
,
Gebicki
J
,
Puhl
H
,
Jurgens
G
:
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
.
Free Radic Biol Med
 
1992
;
13
:
341
390
.
36.
Pierdomenico
SD
,
Lapenna
D
,
Guglielmi
MD
et al.  
:
Target organ status and serum lipids in patients with white coat hypertension
.
Hypertension
 
1995
;
26
:
801
807
.
37.
Pickering
T
:
Recommendations for the use of home (self) and ambulatory blood pressure monitoring
.
Am J Hypertens
 
1995
;
9
:
1
11
.
38.
Lowry
OH
,
Rosenbrough
MJ
,
Farr
AL
,
Randall
RJ
:
Protein measurement with the Folin phenol reagent
.
J Biol Chem
 
1951
;
193
:
265
275
.
39.
Esterbauer
H
,
Stiegl
G
,
Puhl
H
,
Rotheneder
M
:
Continuous monitoring of in vitro oxidation of human low-density lipoprotein
.
Free Radic Res Commun
 
1989
;
6
:
67
75
.
40.
Yagi
K
:
A simple fluorometric assay for lipidperoxide in blood plasma
.
Biochem Med
 
1976
;
15
:
212
216
.
41.
Dillard
CJ
,
Tappel
AL
:
Fluorescent damage products of lipid peroxidation
.
Methods Enzymol
 
1984
;
105
:
337
348
.
42.
Steinbrecher
UP
:
Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products
.
J Biol Chem
 
1987
;
262
:
3603
3608
.
43.
Cominacini
L
,
Garbin
U
,
Davoli
A
et al.  
:
A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification
.
J Lipid Res
 
1991
;
32
:
349
358
.
44.
Fukuda
F
,
Kitada
M
,
Horie
T
,
Awazu
S
:
Evaluation of adriamycin-induced lipid peroxidation
.
Biochem Pharmacol
 
1992
;
,44
:
755
760
.
45.
Kagan
VE
,
Serbinova
EA
,
Forte
T
et al.  
:
Recycling of vitamin E in human low density lipoproteins
.
J Lipid Res
 
1992
;
33
:
385
397
.
46.
Lee
BL
,
Chua
SC
,
Ong
HY
,
Ong
CN
:
High-performance liquid Chromatographic method for routine determination of vitamins A and E and β-carotene in plasma
.
J Chromatogr
 
1992
;
581
:
41
47
.
47.
Mezzetti
A
,
Lapenna
D
,
Pierdomenico
SD
et al.  
:
Vitamins E C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers
.
Atherosclerosis!
 
1995
;
12
:
91
99
.
48.
Altman
DG
:
Practical Statistics for Medical Research
 .
Chapman & Hall
,
London
,
1992
, pp
179
364
.
49.
Avogaro
P
,
Bittolo-Bon
G
,
Cazzolato
G
:
Presence of modified low-density lipoprotein in humans
.
Arteriosclerosis
 
1988
;
8
:
79
87
.
50.
Jialal
I
,
Grundy
SM
:
Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification
.
J Clin Invest
 
1991
;
87
:
597
601
.
51.
Martin
A
,
Frei
B
:
Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells
.
Artrioscler Thromb Vase Biol
 
1997
;
17
:
1583
1590
.
52.
Yoshioka
M
,
Matsushita
T
,
Chuman
Y
:
Inverse association of serum ascorbic acid level and blood pressure or rate of hypertension in male adults aged 30-39 years
.
Int J Vit Nutr Res
 
1984
;
54
:
343
347
.
53.
Salonen
JT
,
Salonen
R
,
Ihanainen
M
et al.  
:
Blood pressure dietary fats and antioxidants
.
Am J Clin Nutr
 
1988
;
48
:
1226
1232
.
54.
Moran
JP
,
Cohen
L
,
Greene
JM
et al.  
:
Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects
.
Am J Clin Nutr
 
1993
;
57
:
213
217
.
55.
Ness
AR
,
Khaw
KT
,
Bingham
S
,
Day
NE
:
Vitamin C status and blood pressure
.
J Hypertens
 
1996
;
14
:
503
508
.
56.
Maziére
C
,
Auclair
M
,
Ronveaux
MF
et al.  
:
Estrogens inhibit copper and cell-mediated modification of low density lipoprotein
.
Atherosclerosis
 
1991
;
89
:
175
182
.
57.
Négre-Salvayre
A
,
Pieraggi
MT
,
Mabile
L
,
Salvayre
R
:
Protective effect of 17/3-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells
.
Atherosclerosis
 
1993
;
99
:
207
217
.
58.
Shwaery
GT
,
Vita
JA
,
Keaney
JF
:
Antioxidant protection of LDL by physiological concentrations of 17/3-estradiol: requirement for estradiol modification
.
Circulation
 
1997
;
95
:
1378
1385
.
59.
Zhu
XD
,
Bonet
B
,
Knopp
RH
:
17 β-Estradiol progesterone and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages
.
Am J Obstet Gynecol
 
1997
;
177
:
196
209
.
60.
Marches
E
,
Martignoni
A
,
Salvini
M
et al.  
:
Carotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertension
.
J Hum Hypertens
 
1996
;
10
:
577
582
.
61.
Roman
MJ
,
Pickering
TG
,
Pini
R
et al.  
:
Prevalence and determinants of cardiac and vascular hypertrophy in hypertension
.
Hypertension
 
1995
;
26
:
369
373
.
62.
Stiko-Rahm
A
,
Hultgardh-Nilsson
A
,
Rengstrom
J
et al.  
:
Oxidized and native LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human arterial smooth muscle cells
.
Arterioscler Thromb
 
1992
;
12
:
1099
1109
.
63.
Rao
GN
,
Berk
BC
:
Active oxygen species stimulate vascular smooth-muscle cell growth and proto-oncogene expression
.
Circ Res
 
1992
;
70
:
593
599
.
64.
Pickering
TG
,
James
GD
:
Determinants and consequences of the diurnal rhythm of blood pressure
.
Am J Hypertens
 
1993
;
6
:
166S
169S
.